You just read:

LISCure Biosciences Has Completed Seed Funding of USD 5 Million for Bacteria-mediated Immunotherapy R&D Enhancement

News provided by

LISCure Biosciences Co., Ltd.

Jul 25, 2019, 09:00 ET